971
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Novel oxazine skeletons as potential antiplasmodial active ingredients: Synthesis, in vitro and in vivo biology of some oxazine entities produced via cyclization of novel chalcone intermediates

, , , &
Pages 569-578 | Received 30 May 2010, Accepted 09 Nov 2010, Published online: 20 Dec 2010

References

  • Fidock DA, Rosenthal PJ, Croft SL, Brun R, Nwaka S. Antimalarial drug discovery: efficacy models for compound screening. Nat Rev Drug Discov 2004;3:509–520.
  • Wiesner J, Ortmann R, Jomaa H, Schlitzer M. New antimalarial drugs. Angew Chem Int Ed Engl 2003;42:5274–5293.
  • Winstaley PA, Parasitol. Today. 2000;16:136–153.
  • Bremen J, Trop A J. Med. Hyg. 2001;64:1–11.
  • Domínguez JN. Chemotherapeutic agents against malaria: what next after chloroquine? Curr Top Med Chem 2002;2:1173–1185.
  • White NJ. Drug resistance in malaria. Br Med Bull 1998;54:703–715.
  • Rosenthal PJ, Miller LH, In Antimalarial Chemotherapy: Mechanisms of Action, Resistance, and New Directions in Drug Discovery; P.J., Rosenthal, Ed, Humana Press Inc.: Totowa, NJ, 2001: pp 3–13.
  • Domínguez JN, Lo´pez S, Charris J, Iarruso L, Lobo G, Semenov A, Olson JE, Rosenthal PJ. J. Med. Chem. 1997;40:2726–2732.
  • Chen M, Theander TG, Christensen SB, Hviid L, Zhai L, Kharazmi A. Licochalcone A, a new antimalarial agent, inhibits in vitro growth of the human malaria parasite Plasmodium falciparum and protects mice from P. yoelii infection. Antimicrob Agents Chemother 1994;38:1470–1475.
  • Chen M, Brøgger Christensen S, Zhai L, Rasmussen MH, Theander TG, Frøkjaer S et al. The novel oxygenated chalcone, 2,4-dimethoxy-4’-butoxychalcone, exhibits potent activity against human malaria parasite Plasmodium falciparum in vitro and rodent parasites Plasmodium berghei and Plasmodium yoelii in vivo. J Infect Dis 1997;176:1327–1333.
  • Li R, Kenyon GL, Cohen FE, Chen X, Gong B, Dominguez JN et al. In vitro antimalarial activity of chalcones and their derivatives. J Med Chem 1995;38:5031–5037.
  • Liu M, Wilairat P, Croft SL, Tan AL, Go ML. Structure-activity relationships of antileishmanial and antimalarial chalcones. Bioorg Med Chem 2003;11:2729–2738.
  • Domı´nguez JN, Charris JE, Lobo G, Gamboa-Domínguez N, Moreno MM, Riggione F, Sa´nchez E, Olson J, Rosenthal PJ. Eur. J. Med. Chem. 2001; 36: 555–560.
  • Vibhute YB and Basser MA. Ind.J. of Chem. 2003;42B:202–205.
  • Bhat BA, Dhar KL, Puri SC, Saxena AK, Shanmugavel M, Qazi GN. Synthesis and biological evaluation of chalcones and their derived pyrazoles as potential cytotoxic agents. Bioorg Med Chem Lett 2005;15:3177–3180.
  • Edwards ML, Stemerick DM, Sunkara PS. Chalcones: a new class of antimitotic agents. J Med Chem 1990;33:1948–1954.
  • Kalirajan R, Palanivelu M, Rajamanickam V, Vinothapooshan G, Anandarajagopal K. Int. J. of Chem. Sci. 2007;5:73–80.
  • Udupi RH, Bhat R, Kumar K. Indian J. Het.Chem. 1998;8:143–146.
  • Pande A and Saxena VK. Ind.J.of Chem. 1987;26B:390–392.
  • Gupta U, Sareen V, Khatri V, Chugh S. Indian J. Het.Chem. 2005;14:265–266.
  • Pandey VK, Gupta VD, Tiwari DN. Indian J. of Het.Chem. 2004;13:399–400.
  • Mishra RM and Wahab A. Indian J. Het.Chem. 2003;13:29–32.
  • Trager W, Jensen JB. Human malaria parasites in continuous culture. Science 1976;193:673–675.
  • Lambros C, Vanderberg JP. Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 1979;65:418–420.
  • Peters W, Portus JH, Robinson BL, Ann. Trop. Med. Parasitol. 1975;69:155–171.
  • Borenfreund E, Puerner JA. Toxicity determined in vitro by morphological alterations and neutral red absorption. Toxicol Lett 1985;24:119–124.
  • Albert A, Serjeant EP, The Determination of Ionization Constants. Chapman and Hall Ltd: London 1971: pp 94.
  • Basilico N, Pagani E, Monti D, Olliaro P, Taramelli D. A microtitre-based method for measuring the haem polymerization inhibitory activity (HPIA) of antimalarial drugs. J Antimicrob Chemother 1998;42:55–60.
  • Baelmans R, Deharo E, Bourdy G, Muñoz V, Quenevo C, Sauvain M et al. A search for natural bioactive compounds in Bolivia through a multidisciplinary approach. Part IV. Is a new haem polymerisation inhibition test pertinent for the detection of antimalarial natural products? J Ethnopharmacol 2000;73:271–275.
  • Meth-Cohn O, Narine B, Tarnowski B. J chem. Soc., Perkin Trans. 1981;1:1520.
  • Ali MM, Tasneem Rajanna, KC, Sai Prakash PK. Synlett. 2001;2:251.
  • Kaschula CH, Egan TJ, Hunter R, Basilico N, Parapini S, Taramelli D et al. Structure-activity relationships in 4-aminoquinoline antiplasmodials. The role of the group at the 7-position. J Med Chem 2002;45:3531–3539.
  • Hawley SR, Bray PG, Mungthin M, Atkinson JD, O’Neill PM, Ward SA. Relationship between antimalarial drug activity, accumulation, and inhibition of heme polymerization in Plasmodium falciparum in vitro. Antimicrob Agents Chemother 1998;42:682–686.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.